Carregant...
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/220685
Empirical antibiotic therapy improves outcomes in mechanically ventilated patients with COVID-19: An emulated targeted trial within a prospective, multicentre cohort study
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Background: Bacterial pulmonary superinfections develop in a substantial proportion of mechanically ventilated COVID-19 patients and are associated with prolonged mechanical ventilation requirements and increased mortality. Albeit recommended, evidence supporting the use of empirical antibiotics at intubation is weak and of low quality. The aim of this study was to elucidate the effect of empirical antibiotics, administered within 24 h of endotracheal intubation, on superinfections, duration of mechanical ventilation, and mortality in mechanically ventilated patients with COVID-19. Methods: Emulated targeted trial by means of a propensity score-matched analysis of a prospective multicentre cohort study of consecutive mechanically ventilated patients admitted to 62 Spanish intensive care units suffering from COVID-19 between March 2020 and February 2021. Results: Overall, 8532 critically ill COVID-19 patients were included, of which 2580 mechanically ventilated patients remained after matching. Empirical antibiotics were prescribed to 1665 (64%) at intubation. Pulmonary superinfections developed in 39% and 47% of patients treated with and without empirical antibiotics, respectively (p < 0.01). Patients treated with empirical antibiotics had a shorter duration of mechanical ventilation (incidence risk ratio: 0.85 [95% confidence interval (CI), 0.78 - 0.94], p < 0.01) and a reduced stay in the intensive care unit (incidence risk ratio: 0.89 [95% CI, 0.82 - 0.97] days, p < 0.01). Mortality 28 days after endotracheal intubation was 28% in patients treated with empirical antibiotics as opposed to 32% in patients treated without (odds ratio: 0.76 [95% CI, 0.61 - 0.94], p < 0.01). Conclusion: The administration of empirical antibiotics at intubation in mechanically ventilated COVID-19 patients was associated with a reduced incidence of pulmonary superinfections, a shorter duration of mechanical ventilation and intensive care unit stay, and a lower mortality rate. Notwithstanding these benefits, the applicability of these findings to other viral pneumonias and beyond the pandemic context remains uncertain. Registration: www.clinicaltrials.gov (NCT04457505).
Matèries
Matèries (anglès)
Citació
Citació
WENDEL GARCIA, Pedro david, CECCATO, Adrian, MOTOS, Ana, FRANCH LLASAT, Diego, PÉREZ MORENO, Ma. del mar olga, DOMENECH SPANEDDA, Marie f., CHAMARRO MARTÍ, Elena, FERRER, Ricard, FERNÁNDEZ BARAT, Laia, RIERA, Jordi, ÁLVAREZ NAPAGAO, Sergio, PEÑUELAS, Oscar, LORENTE, J. a. (josé ángel), ALMANSA, Raquel, GABARRÚS, Albert, GONZALO CALVO, David de, GONZÁLEZ, Jessica, AÑON, Jose manuel, BARBERÀ, Carme, BARBERÁN, José, BLANDINO ORTIZ, Aaron, BUSTAMANTE MUNGUIRA, Elena, CABALLERO, Jesús, CARBAJALES PÉREZ, Cristina, CARBONELL, Nieves, CATALÁN GONZÁLEZ, Mercedes, BARRAL SEGADE, Patricia, MAÑEZ, Rafael, TORRE, Maria del carmen de la, DÍAZ, Emili, ESTELLA, Ángel, GALLEGO, Elena, GARCÍA GARMENDIA, José luís, GARNACHO MONTERO, José, AMAYA VILLAR, Rosario, GÓMEZ, José m., HUERTA, Arturo, JORGE GARCÍA, Ruth noemí, LOZA VÁZQUEZ, Ana, MARIN CORRAL, Judith, MARTIN DELGADO, María cruz, MARTÍNEZ DE LA GÁNDARA, Amalia, MARTÍNEZ VARELA, Ignacio, LÓPEZ MESSA, Juan, MUÑIZ ALBAICETA, Guillermo, NOVO, Mariana andrea, PEÑASCO, Yhivian, POZO LADERAS, Juan carlos, RICART, Pilar, SÁNCHEZ MIRALLES, Angel, SANCHO, Susana, SOCIAS, Lorenzo, SOLÉ VIOLÁN, Jordi, SUÁREZ SIPMANN, Fernando, TAMAYO, Luis, TRENADO ÁLVAREZ, José, BARBÉ, Ferran, TORRES MARTÍ, Antoni, ROCHE CAMPO, Ferran, CIBERESUCICOVID investigators. Empirical antibiotic therapy improves outcomes in mechanically ventilated patients with COVID-19: An emulated targeted trial within a prospective, multicentre cohort study. _Journal of Infection_. 2025. Vol. 90, núm. 2. [consulta: 25 de febrer de 2026]. ISSN: 0163-4453. [Disponible a: https://hdl.handle.net/2445/220685]